Priya Singhal, MD, MPH, is Executive Vice President and Head of Development at Biogen, where she leads the company’s pipeline and has contributed more than a decade of scientific leadership. She has guided over a dozen product approvals and more than 150 development programs, advancing treatments for serious and rare diseases. Before Biogen, Dr. Singhal held senior R&D roles at Zafgen Inc., Vertex Pharmaceuticals, and Millennium Pharmaceuticals. She earned her MPH from the Harvard School of Public Health, her MD in Internal Medicine in Mumbai, India, and is an invited speaker and guest faculty lecturer at Harvard Medical School.
